Wordt geladen...
Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases
Since the 1950s, replacement of immunoglobulin G using human immunoglobulin has been the standard treatment for primary immunodeficiency diseases with defects in antibody production. These patients suffer from recurrent and severe infections, which cause lung damage and shorten their life span. Immu...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3430092/ https://ncbi.nlm.nih.gov/pubmed/22956859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S25188 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|